|
|
Volumn 8, Issue 4, 2020, Pages e21-
|
|
Correction to Lancet Respir Med 2020; 8: e21 (The Lancet Respiratory Medicine (2020) 8(4) (e21), (S2213260020301168), (10.1016/S2213-2600(20)30116-8));Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2,4 THIAZOLIDINEDIONE DERIVATIVE;
ANGIOTENSIN 1 RECEPTOR ANTAGONIST;
ANGIOTENSIN CONVERTING ENZYME 2;
CALCIUM CHANNEL BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
IBUPROFEN;
2019 NOVEL CORONAVIRUS;
ALTERNATIVE MEDICINE;
ASIAN;
BLOOD VESSEL;
CEREBROVASCULAR ACCIDENT;
COMORBIDITY;
CORONAVIRINAE;
CORONAVIRUS DISEASE 2019;
CORONAVIRUS INFECTION;
DIABETES MELLITUS;
DISEASE COURSE;
DRUG MONITORING;
ENZYME ACTIVITY;
EPITHELIUM CELL;
GENETIC PREDISPOSITION;
HOSPITAL ADMISSION;
HUMAN;
HYPERTENSION;
INFECTION RISK;
INSULIN DEPENDENT DIABETES MELLITUS;
INTENSIVE CARE UNIT;
INTESTINE EPITHELIUM CELL;
ISCHEMIC HEART DISEASE;
KIDNEY EPITHELIUM;
LETTER;
LUNG ALVEOLUS EPITHELIUM CELL;
MALIGNANT NEOPLASM;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PNEUMONIA;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
PROTEIN POLYMORPHISM;
SEVERE ACUTE RESPIRATORY SYNDROME;
SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2;
UPREGULATION;
BETACORONAVIRUS;
CHINA;
CRITICAL ILLNESS;
PANDEMIC;
RETROSPECTIVE STUDY;
SARS CORONAVIRUS;
VIRUS PNEUMONIA;
BETACORONAVIRUS;
CHINA;
CORONAVIRUS INFECTIONS;
CRITICAL ILLNESS;
DIABETES MELLITUS;
HUMANS;
HYPERTENSION;
PANDEMICS;
PNEUMONIA, VIRAL;
RETROSPECTIVE STUDIES;
SARS VIRUS;
|
|
EID: 85082085547
PISSN: 22132600
EISSN: 22132619
Source Type: Journal
DOI: 10.1016/S2213-2600(20)30235-6 Document Type: Erratum |
|
Times cited : (2276)
|
|
References (5)
|
